Cognition Therapeutics In...
(CGTX)
undefined
undefined%
At close: undefined
0.48
-1.19%
After-hours Dec 13, 2024, 07:37 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Revenue | - | - | - | - | - |
Cost of Revenue | 252.00K | 235.00K | 93.00K | 98.00K | 81.00K |
Gross Profit | -252.00K | -235.00K | -93.00K | -98.00K | -81.00K |
Operating Income | -50.72M | -43.55M | -28.60M | -17.41M | -17.83M |
Interest Income | 27.00K | 22.22M | 17.45M | 10.86M | 13.16M |
Pretax Income | -25.79M | -21.40M | -11.72M | -7.84M | -4.84M |
Net Income | -25.79M | 757.00K | -10.29M | -10.07M | -6.95M |
Selling & General & Admin | 13.53M | 13.23M | 10.03M | 4.52M | 3.45M |
Research & Development | 37.20M | 30.32M | 18.57M | 12.89M | 14.38M |
Other Expenses | - | -22.22M | -17.45M | -10.86M | -13.16M |
Operating Expenses | 50.72M | 21.33M | 11.15M | 6.55M | 4.67M |
Interest Expense | - | 28.00K | 893.00K | 1.75M | 1.02M |
Selling & Marketing Expenses | - | - | - | - | - |
Cost & Expenses | 50.72M | 21.33M | 11.15M | 6.55M | 4.67M |
Income Tax | - | -22.15M | -1.43M | 2.23M | 2.11M |
Shares Outstanding (Basic) | 29.99M | 28.99M | 22.23M | 21.94M | 21.94M |
Shares Outstanding (Diluted) | 30.03M | 28.99M | 22.23M | 21.94M | 21.94M |
EPS (Basic) | -0.86 | 0.03 | -0.46 | -0.46 | -0.32 |
EPS (Diluted) | -0.86 | 0.03 | -0.46 | -0.46 | -0.32 |
EBITDA | -25.51M | -21.13M | -13.38M | -5.99M | -3.50M |
Depreciation & Amortization | 252.00K | 235.00K | 93.00K | 98.00K | 81.00K |